Cargando…
Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405508/ https://www.ncbi.nlm.nih.gov/pubmed/34159497 http://dx.doi.org/10.1007/s10928-021-09760-1 |
_version_ | 1783746349859078144 |
---|---|
author | Välitalo, Pyry Antti Juhana |
author_facet | Välitalo, Pyry Antti Juhana |
author_sort | Välitalo, Pyry Antti Juhana |
collection | PubMed |
description | Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline several methods for using aggregate data as the basis of parameter estimation. The presented methods can be used for estimation of parameters from aggregate data, and as a computationally efficient alternative for the stochastic simulation and estimation procedure. They also allow for population PK/PD optimal design in the case when the data-generating model is different from the data-analytic model, a scenario for which no solutions have previously been available. Mathematical analysis and computational results confirm that the aggregate-data FO algorithm converges to the same estimates as the individual-data FO and yields near-identical standard errors when used in optimal design. The aggregate-data MC algorithm will asymptotically converge to the exactly correct parameter estimates if the data-generating model is the same as the data-analytic model. The performance of the aggregate-data methods were also compared to stochastic simulations and estimations (SSEs) when the data-generating model is different from the data-analytic model. The aggregate-data FO optimal design correctly predicted the sampling distributions of 200 models fitted to simulated datasets with the individual-data FO method. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-021-09760-1. |
format | Online Article Text |
id | pubmed-8405508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84055082021-09-09 Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models Välitalo, Pyry Antti Juhana J Pharmacokinet Pharmacodyn Original Paper Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline several methods for using aggregate data as the basis of parameter estimation. The presented methods can be used for estimation of parameters from aggregate data, and as a computationally efficient alternative for the stochastic simulation and estimation procedure. They also allow for population PK/PD optimal design in the case when the data-generating model is different from the data-analytic model, a scenario for which no solutions have previously been available. Mathematical analysis and computational results confirm that the aggregate-data FO algorithm converges to the same estimates as the individual-data FO and yields near-identical standard errors when used in optimal design. The aggregate-data MC algorithm will asymptotically converge to the exactly correct parameter estimates if the data-generating model is the same as the data-analytic model. The performance of the aggregate-data methods were also compared to stochastic simulations and estimations (SSEs) when the data-generating model is different from the data-analytic model. The aggregate-data FO optimal design correctly predicted the sampling distributions of 200 models fitted to simulated datasets with the individual-data FO method. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-021-09760-1. Springer US 2021-06-22 2021 /pmc/articles/PMC8405508/ /pubmed/34159497 http://dx.doi.org/10.1007/s10928-021-09760-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Välitalo, Pyry Antti Juhana Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title | Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title_full | Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title_fullStr | Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title_full_unstemmed | Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title_short | Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
title_sort | pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405508/ https://www.ncbi.nlm.nih.gov/pubmed/34159497 http://dx.doi.org/10.1007/s10928-021-09760-1 |
work_keys_str_mv | AT valitalopyryanttijuhana pharmacometricestimationmethodsforaggregatedataincludingdatasimulatedfromotherpharmacometricmodels |